А. В. Султанбаев

1.7k citations

53 papers · 63 · h-index 4

Impact in

Oncology
- PARP inhibition in cancer therapy
Cancer Research
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics

Papers in

Oncology 32
- PARP inhibition in cancer therapy 8
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 4
Pulmonary and Respiratory Medicine 20
- Advanced Breast Cancer Therapies 9
- Renal cell carcinoma treatment 5

Co-authors: С. П. Иванов (1 shared paper)А. А. Измайлов (17 shared papers)Eric Jonasch (1 shared paper)Sergey Cheporov (1 shared paper)Ilya Tsimafeyeu (4 shared papers)D.А. Kudlаy (3 shared papers)В. Н. Павлов (1 shared paper)Dina Sakaeva (1 shared paper)
Journals: Journal of Clinical Oncology (3 papers)Annals of Oncology (3 papers)ESMO Open (1 paper)Cancer Research (1 paper)European Journal of Cancer (1 paper)
Partner nations: Russia Indonesia Rwanda

In The Last Decade

А. В. Султанбаев

31 papers receiving 61 citations

Peers

Countries citing papers authored by А. В. Султанбаев

Since Specialization

Citations

This map shows the geographic impact of А. В. Султанбаев's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. В. Султанбаев with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. В. Султанбаев more than expected).

Fields of papers citing papers by А. В. Султанбаев

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. В. Султанбаев. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. В. Султанбаев. The network helps show where А. В. Султанбаев may publish in the future.

Co-authors

The 25 scholars most cited alongside А. В. Султанбаев, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with А. В. Султанбаев Line = papers co-authored together А. В. Султанбаев links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Synthesis and Properties of Chitosan- and Pectin-Based Hydrogels Colloid Journal ·Н. Н. Сигаева, Р. Р. Вильданова, А. В. Султанбаев, С. П. Иванов	2020	6
2	A Phase 2 Open-Label Study of Belzutifan (a HIF-2[alpha] Inhibitor) Monotherapy in Patients with Advanced/Metastatic Pheochromocytoma/Paraganglioma or Pancreatic Neuroendocrine Tumors Endocrine Abstracts ·Camilo Jiménez, Julien Hadoux, Rivero Jaydira Del, Satya N. Das, Othon Iliopoulos, А. В. Султанбаев, Е. В. Артамонова, Eric Jonasch, Karel Pacák, Wei Wang, Fan Jin, Naik Girish S., Jaume Capdevila	2023	5
3	The effectiveness and safety of eribulin therapy in HR-positive HER2-negative metastatic breast cancer post-CDK4/6 inhibitor therapy in Russian clinical practice. Journal of Clinical Oncology ·I. V. Kolyadina, Л. В. Болотина, Lyudmila Zhukova, Liubov Yu Vladimirova, А. В. Султанбаев, Е. В. Карабина, I. P. Ganshina, Е. Г. Овчинникова, I. V. Kolyadina, Galina Antonova, Mikhail Volkonsky, James J. Kolokolov, Е. П. Зуева, Inessa K. Akopyan, Natalia Fadeeva, Irina Evstigneeva, Светлана Орлова, Anna Vasilevskaya, Oxana Shalaeva, Oxana Shirokova	2021	4
4	Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer Tumors of female reproductive system ·А. Ф. Насретдинов, Н. И. Султанбаева, Ш. И. Мусин, А. В. Пушкарев, К. V. Menshikov, В. А. Пушкарев, А. В. Султанбаев	2020	4
5	Organization of screening for prostate cancer in carriers of germinal mutations in the BRCA1 / 2 genes European Urology Open Science ·А. В. Султанбаев, К. V. Menshikov, Н. И. Султанбаева, А. Ф. Насретдинов, Илдар Минниахметов, Ш. И. Мусин, А. А. Измайлов	2020	3
6	12P EGFR gene mutations landscape at lung cancer in a multinational region located in the southeast of the European part of Russia Annals of Oncology ·А. В. Султанбаев, А. Ф. Насретдинов, Н. И. Султанбаева, Илдар Минниахметов, К. V. Menshikov, Ш. И. Мусин	2020	3
7	25P Identification of gene mutations in patients with breast cancer in a region located in the southeast of the European part of Russia Annals of Oncology ·А. В. Султанбаев, Илдар Минниахметов, Н. И. Султанбаева, К. V. Menshikov, А. Ф. Насретдинов, Ш. И. Мусин	2020	3
8	The «in vivo» study of blood 5-fluorouracil content by quenching of intrinsic protein fluorescence Journal of Luminescence ·R. R. Kayumova, А. В. Султанбаев, С. С. Остахов, С. Л. Хурсан, М. Ф. Абдуллин, Ш. Х. Ганцев, Dina Sakaeva	2017	3
9	Hereditary prostate cancer screening European Urology Open Science ·А. В. Султанбаев, А. Ф. Насретдинов, Н. И. Султанбаева, К. V. Menshikov, Ш. И. Мусин, А. А. Измайлов, Илдар Минниахметов	2020	2
10	Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review Journal of Modern Oncology ·К. V. Menshikov, А. В. Султанбаев, Kamila T. Akhmetgareeva, D. О. Lipatov	2021	2
11	ADAM: A multicenter, non-interventional, prospective cohort study for determination of prevalence of homologous recombination repair genes mutations (HRRm) in metastatic castrate-resistant prostate cancer (mCRPC)—Interim analysis. Journal of Clinical Oncology ·B. Ya. Alexeev, L. N. Lyubchenko, M. Gordiev, М. Л. Филипенко, Yulia Anzhiganova, А. В. Султанбаев, Alexander Bystrov, А. С. Орлов, Galina Gopp, Evgeny Kopyltsov, А. П. Лыков, Vagif Atduev, Галина Алексеева, O. A. Mailyan, В. М. Семенов, Olga Vedrova, A. G. Perevoschikov, Сергей Андреев, Logacheva Evgenia	2022	2
12	Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review Creative Surgery and Oncology ·К. V. Menshikov, А. В. Султанбаев, Ш. И. Мусин, И. Р. Рахматуллина, I. A. Menshikovа, R. R. Abdeev, Н. И. Султанбаева, E. V. Popova, G. A. Serebrennikov	2022	2
13	Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene Meditsinskiy sovet = Medical Council ·А. Ф. Насретдинов, Н. И. Султанбаева, Ш. И. Мусин, Oleg Lipatov, А. А. Измайлов, R. Т. Ayupov, К. V. Menshikov, А. В. Пушкарев, А. В. Султанбаев	2020	2
14	Организация онкологической службы Республики Башкортостан Malignant tumours ·М. В. Забелин, А. А. Измайлов, Р. Т. Аюпов, Л. К. Закирова, Э. Р. Волынцева, Р. Р. Рахимов, А. В. Султанбаев	2021	2
15	Management strategy for cancer patients in the context of the COVID-19 epidemic Seminars in Oncology ·А. А. Измайлов, Ozal Beylerli, В. Н. Павлов, Ilgiz Gareev, М. В. Забелин, Rustem Ayupov, Ш. И. Мусин, А. В. Султанбаев	2020	2
16	58P Quantitative indicators of TREC and KREC excision rings in breast cancer ESMO Open ·А. В. Султанбаев, Ш. И. Мусин, К. V. Menshikov, Н. И. Султанбаева, А. Ф. Насретдинов, I. A. Menshikovа, M. Sultanbaev, D.А. Kudlаy, А.П. Продеус	2023	2
17	Sequential anticancer therapy in a patient with metachronous primary uterine cancer and breast cancer Malignant tumours ·А. В. Султанбаев, А. Ф. Насретдинов, Н. И. Султанбаева, К. V. Menshikov, Ш. И. Мусин, А. А. Измайлов, Oleg Lipatov, В. А. Пушкарев, Р. Б. Валиахмедов, А. В. Пушкарев, Ф. Ф. Муфазалов	2021	1
18	Immunotherapy of advanced hepatocellular carcinoma: case report and literature review Meditsinskiy sovet = Medical Council ·К. V. Menshikov, А. В. Султанбаев, Ш. И. Мусин, I. A. Menshikovа, R. R. Abdeev, Н. И. Султанбаева, V. G. Nigmatullin, E. V. Popova	2022	1
19	Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice Russian Journal of Gastroenterology Hepatology Coloproctology ·В. В. Петкау, А. В. Султанбаев, К. V. Menshikov, A. S. Antipin, M. V. Volkonsky, V. M. Filippova, Yu. V. Vasilyeva, А. А. Тарханов, M. R. Mukhitova, Makhabbat Zh. Murzalina, A. R. Safarova	2022	1
20	Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study Journal of Modern Oncology ·М. И. Волкова, А. S. Kalpinskiy, К. V. Menshikov, Lilia V. Gorbuleva, А. В. Султанбаев, О. I. Evsyukova, Varazdat R. Meltonian, С В Мишугин, М. Р. Матуров, A. S. Olshanskaya, Dmitrii Iu. Shemetov, Tatyana A. Sannikova, M. V. Makhnutina, Marina A. Filipieva, Elena A. Gaijsina, E. G. Ovchinnikova, Ovsep A. Mailian, B. Yа. Alekseev, В. Б. Матвеев	2023	1

About А. В. Султанбаев

А. В. Султанбаев is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Genetics and Molecular Biology, having authored 53 papers that have together received 63 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (9 papers), Advanced Breast Cancer Therapies (9 papers), PARP inhibition in cancer therapy (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Renal cell carcinoma treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (29 citations), Cancer Research (16 citations), Molecular Medicine (5 citations), Hepatology (6 citations) and Pathology and Forensic Medicine (11 citations). А. В. Султанбаев has collaborated with scholars based in Russia, Indonesia and Rwanda. Frequent co-authors include С. П. Иванов, А. А. Измайлов, Eric Jonasch, Sergey Cheporov, Ilya Tsimafeyeu, D.А. Kudlаy, В. Н. Павлов, Dina Sakaeva, Fan Jin and Galina Antonova. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, ESMO Open, Cancer Research and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

А. В. Султанбаев

Impact in

Papers in i

In The Last Decade

А. В. Султанбаев

Peers

Countries citing papers authored by А. В. Султанбаев

Fields of papers citing papers by А. В. Султанбаев

All Works

About А. В. Султанбаев

Explore authors with similar magnitude of impact

Papers in